Wednesday, July 15, 2020 12:57:30 AM
Sample of his tweets. scroll through them on twitter:
"Algernon co's repurposed drug, Ifenprodil is exactly promise. This drug modifys NMDA receptor activity and
cures COVID-19 ALI, which indicates that our blood HCA is very danger. Because HCA is a strong agonist for NMDA receptor."
"COVID-19 has an another face to neurological disease. Loss of sense of smell and taste. unconsciousness.
COVID-19 induces NMDA receptor abnormality with cooperation with our blood HCA."
"Why did our Japanese die very fewer than European and American by COVID-19? Prof. Yamanaka pointed out factor-X. What is factor-X? Do you know Ifenprodil drug of Algernon co. for the treatment of COVID-19 ALI? This is a hint. Ifenprodil inhibits NMDA recep."
"This Ifenprodil inhibits lung cell NMDA receptor which induces COVID-19-induced cytokine storm. Our homocysteic acid (HCA) is a strong agonist of NMDA receptor.
Our Japanese HCA level might be lower than that of European and American. That is factor-X."
https://twitter.com/Hasetohru
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM